Latest Entitlement Offer News

European Resources Limited (ASX: ERE) has announced a $4.26 million renounceable entitlement offer to accelerate exploration and metallurgical work at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, providing shareholders with a strategic opportunity amid significant recent resource growth.

Percheron Therapeutics has announced a $2.2 million non-renounceable entitlement offer at a 20% discount, including free options, to fund the next phase of its lead oncology asset HMBD-002.

Regener8 Resources has announced a $2.03 million entitlement offer at a 41% discount, aiming to accelerate exploration and acquisition of its Srebrenica North Project. Eligible shareholders can subscribe at one new share for every two held, positioning the company for its next growth phase.

NuEnergy Gas Limited has completed four wells under its Tanjung Enim Early Gas Sales Initiative, secured a binding gas sales agreement, and raised $3.5 million to advance its Indonesian coal bed methane projects.

Regener8 Resources has raised $800,000 through a share placement to fund its strategic acquisition and exploration at the promising Srebrenica North Project in Bosnia. The company also plans a further entitlement offer to bolster its capital position.

Bapcor Limited has initiated a fully underwritten $200 million equity raising at $0.60 per share, aiming to reduce debt and support a strategic turnaround under new leadership. The retail entitlement offer opened on 5 March and closes on 19 March 2026.

Horizon Gold Limited has raised A$30 million through a placement and entitlement offer to accelerate exploration and advance the feasibility study at its Gum Creek Gold Project in Western Australia.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Merino & Co. Limited reported a 60.5% drop in revenue and a 28.2% increase in net loss for the half-year ending December 2025, reflecting a strategic investment phase aimed at future growth. The company is expanding production capacity and building inventory ahead of wholesale expansion, signaling a pivot towards revenue acceleration.

TerraCom Limited reported a significant half-year loss amid falling coal prices and production challenges, completing a $56 million capital raise to strengthen its financial position.

Associate Global Partners Limited reported a significantly reduced half-year loss and modest growth in funds under management, underpinned by strong inflows and strategic capital raising.

Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.